Pharmaceutical customers will benefit from a breakthrough in pharmaceutical glass technology while patients will access safer medicines and vaccines.
Stevanato Group, specializing in glass pharmaceutical primary packaging, glass converting machines, visual inspection systems, assembling and packaging machines for the pharmaceutical industry, announces that Monica de Virgiliis has been appointed as a member of its Board of Directors.
The construction works for the new production plant of Stevanato Group officially started today at Sete Lagoas (Minas Gerais) in Brazil, with the traditional groundbreaking ceremony, at the presence of local Authorities and company management. The Group located in Piombino Dese (Padua - Italy) is specialized in the production of glass pharamaceutical primary packaging, in the technology for the development of glass tube forming machines, visual inspection machines, assembly and packaging machines, serialization solutions.
The Stevanato Group website was awarded the first prize MEDIASTARS, the Technical Award for Italian Advertising in the "Internet - Corporate Websites" section.
The awards ceremony of the XIX edition winning projects of the Mediastars prize took place on 12th June 2015. It is one of the most prestigious prizes at Italian level for the realization of Advertising, Corporate Design and Multimedia Communication Campaigns.
Stevanato Group, international leader in the production of insulin cartridges and glass containers for pharmaceutical use, in technology for glass tube forming machines and visual inspection machines, announces that Prof. Fabio Buttignon joined the Company as member of the Board of Directors.
An exhibition called "Vetro Murrino, da Altino a Murano", sponsored by Stevanato Group, will take place starting from 17th June 2012 until 6th January 2013.
"Organic growth", said Company President Cav. Sergio Stevanato, "is the basis of every solid industrial company. That's why, in keeping with our business plan, we have decided to begin doubling the plant in Mexico. The investment plan will initially open with the amount of 4.5 million Euros, which is expected to double early in 2012, and will reach 30 million by the time the plant has been completed."
Venice, October 28, 2009 - Today the Island of San Giorgio in Venice hosted 300 representatives of the leading players in the worldwide pharmaceutical industry for a meeting on quality, product and service innovation, and internationalization.